WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 3:02 pm Sale |
2022-12-30 | 13G | Nektar Therapeutics NKTR |
WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% |
-758,915 (Position Closed) |
Filing |
| 2022-02-04 09:29 am Sale |
2021-12-31 | 13G | Nektar Therapeutics NKTR |
WELLINGTON MANAGEMENT GROUP LLP | 758,915 6.170% |
-133,926 (-15.00%) |
Filing |
| 2021-02-04 11:31 am Sale |
2020-12-31 | 13G | Nektar Therapeutics NKTR |
WELLINGTON MANAGEMENT GROUP LLP | 892,841 7.470% |
-187,038 (-17.32%) |
Filing |